China, Aug. 26 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'A Prospective Study on Predicting Recurrence Risk of Postoperative High-risk GISTs in NED State Based on MRD Detection via Liquid Biopsy'. The following are the other relevant details related to the trial:
Registration Number: ChiCTR2600130852
Registration Time: 2026/08/25
Type: Diagnostic test
Primary Sponsor: Peking University People's Hospital
To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=336792
Published by HT Digital Content Services with permission from Health Daily Digest....